ARTICLE | Company News
Grunenthal, KU Leuven partner to develop non-opioid pain candidates
April 20, 2018 7:50 PM UTC
Grünenthal Group (Aachen, Germany) partnered with the Centre for Drug Design and Discovery (CD3) and the Laboratory of Ion Channel Research (LICR) at Catholic University Leuven (Leuven, Belgium) to develop non-opioid compounds to treat pain...